SEC Form 4 · accession 0001645627-17-000143
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 27, 2017
Accepted (ET)
Dec 1, 2017 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2017 | P | 3,000 | $0.065 | A | 24,276,189 | D | |
| Common Stock | Nov 27, 2017 | P | 3,000 | $0.065 | A | 24,279,189 | D | |
| Common Stock | Nov 27, 2017 | P | 3,000 | $0.065 | A | 24,282,189 | D | |
| Common Stock | Nov 27, 2017 | P | 3,000 | $0.066 | A | 24,285,189 | D | |
| Common Stock | Nov 27, 2017 | P | 3,000 | $0.0648 | A | 24,288,189 | D | |
| Common Stock | Nov 27, 2017 | P | 2,000 | $0.0649 | A | 24,290,189 | D | |
| Common Stock | Nov 28, 2017 | P | 3,000 | $0.06 | A | 24,293,189 | D | |
| Common Stock | Nov 29, 2017 | P | 3,000 | $0.0664 | A | 24,296,189 | D | |
| Common Stock | Nov 29, 2017 | P | 3,000 | $0.065 | A | 24,299,189 | D | |
| Common Stock | Nov 29, 2017 | P | 3,000 | $0.0649 | A | 24,302,189 | D | |
| Common Stock | Nov 29, 2017 | P | 3,000 | $0.0642 | A | 24,305,189 | D |
Table II — derivative securities
No Table II lines on this filing.